What Effect Do Surgical Choices Have on Quality of Life in Young Breast Cancer Survivors?
Unilateral or bilateral mastectomy can have a significant effect on quality of life when compared with breast-conserving surgery in young breast cancer survivors. (Source: CancerNetwork)
Source: CancerNetwork - December 7, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Patients Say Quality of Life Suffered With Mastectomy for Early Breast Cancer
(MedPage Today) -- Breast-conservation options were associated with better sexual, psychosocial outcomes (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 7, 2018 Category: Hematology Source Type: news

For Younger Cancer Patients, Mastectomy vs. Breast - Conserving Surgery
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 7, 2018 Category: Cancer & Oncology Tags: Oncology, Surgery, News, Source Type: news

For Younger Cancer Patients, Mastectomy vs. Breast-Conserving Surgery
FRIDAY, Dec. 7, 2018 -- Younger breast cancer patients who have one or both breasts removed have lower levels of satisfaction and well-being than those who have breast-conserving surgery, a new study finds. The study included 560 women diagnosed... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2018 Category: General Medicine Source Type: news

Choice of surgery may affect quality of life for young breast cancer survivors
(American Association for Cancer Research) Younger breast cancer patients who underwent mastectomy reported lower breast satisfaction and poorer psychosocial and sexual well-being compared with those who underwent breast-conserving surgery, according to results of a trial presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 7, 2018 Category: Cancer & Oncology Source Type: news

For Younger Cancer Patients, Mastectomy vs. Breast-Conserving Surgery
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 7, 2018 Category: Cancer & Oncology Source Type: news

For Younger Cancer Patients, Mastectomy vs. Breast-Conserving Surgery
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - December 7, 2018 Category: Cancer & Oncology Source Type: news

Merit Puts a Bow On Cianna Medical Acquisition
Merit Medical Systems has completed the acquisition of Aliso Viejo, CA-based, Cianna Medical. The South Jordan, UT-based company put an upfront payment of $135 million with potential earn-out payments of an additional $15 million for achievement of supply chain and scalability metrics, and up to an additional $50 million for achievement of sales milestones. Merit said that Cianna specializes in wire-free breast localization and has been focused on breast conservation for 11 years. Its research, development and commercialization teams developed a non-radioactive, wire-free breast localization system and technology that uses...
Source: MDDI - November 14, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with 'good risk'
(American Society for Radiation Oncology) A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report. These 12-year follow-up data from the only prospective, randomized trial to compare recurrence outcomes after treatment for low-risk ductal carcinoma in situ (DCIS) were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2018 Category: Cancer & Oncology Source Type: news

When Opioids for Cancer Pain Go Wrong: Clin Onc News Report
(MedPage Today) -- Also, breast-conserving surgery or mastectomy? (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - August 15, 2018 Category: OBGYN Source Type: news

Hologic buys Faxitron for $85M
Moving to expand its presence in the breast-conserving surgery market, women's...Read more on AuntMinnie.comRelated Reading: Hologic appoints new CFO Hologic wins $4.8M in patent lawsuit against Minerva Judge finds in favor of Hologic in Fujifilm patent lawsuit Faxitron acquires Precision X-Ray assets FDA clears Faxitron's 3D CT breast system Faxitron to double sales team in 2018 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 2, 2018 Category: Radiology Source Type: news

Could Faxitron Really Be the Perfect Tuck-in for Hologic?
In a move to broaden and further strengthen its breast health portfolio, Hologic said it has acquired digital specialist Faxitron Bioptics for $85 million. Tucson, AZ-based Faxitron markets a broad portfolio of products across major categories including digital specimen radiography, breast lesion localization, and sentinel lymph node biopsy. The company most recently launched the VisionCT. The technology is a 3-D breast specimen-designated CT system to offer 360-degree images of excised lesions. “Faxitron's market-leading products, which span from digital specimen radiography to breast lesion localization...
Source: MDDI - August 1, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Potential New Surgical Options for Women with Multiple Ipsilateral Breast Cancer
A newly published collaborative national study finds that most women with two or three sites of cancer in a single breast can successfully complete breast conservation therapy rather than mastectomy. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - July 16, 2018 Category: Hospital Management Authors: Geisel Communications Tags: News Research breast cancer Norris Cotton Cancer Center Source Type: news

Potential new surgical options for women with multiple ipsilateral breast cancer
(Dartmouth-Hitchcock Medical Center) Initial results of a new national clinical trial show that the majority of women with breast cancer who have two to three sites of disease in a single breast at the time of diagnosis are able to successfully complete breast-conserving surgery without conversion to mastectomy. This is the first prospective study to assess this possibility, and its findings improve the surgical choices available to women with multiple ipsilateral breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 12, 2018 Category: Cancer & Oncology Source Type: news

Meta-analysis: Recurrence Rates After Lumpectomy Have Improved Meta-analysis: Recurrence Rates After Lumpectomy Have Improved
More than ever before, breast-conserving surgery is a treatment option for more breast cancer patients, say experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medicaid expansion in Kentucky improves breast cancer care for women 20 to 64 years old
(American College of Surgeons) In Kentucky, one of the Medicaid expansion states, a University of Louisville study of breast cancer care has found a connection between Medicaid expansion and improved quality of breast cancer care, including an increase in diagnosis of early stage disease and greater utilization of breast-conserving surgery instead of more invasive operations such as mastectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial
This research article has led to a Practice Changing Update in DynaMed Plus. It concludes that radioactive seed localization may have similar positive margin but higher successful placement rates compared to wire localization in women having breast-conserving surgery for nonpalpable invasive breast cancer or ductal carcinoma in situ (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 18, 2018 Category: Consumer Health News Source Type: news

FDA clears Xcision Medical ’ s GammaPod breast cancer device
The FDA said today that it granted 510(k) clearance to the GammaPod stereotactic radiotherapy device made by Xcision Medical Systems to treat breast cancer. The federal safety watchdog said the GammaPod is designed to treat a portion of the breast in conjunction with breast-conserving surgery. It uses an array of 36 Cobalt-60 sources to beam radiation from within a two-layer vacuum cup that immobilizes the breast to minimize damage to adjacent healthy tissue. GammaPod is not intended to replace whole-breast radiation therapy and has not been shown to be as effective as that technique, the FDA said. The clearance was b...
Source: Mass Device - December 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Radiosurgery Regulatory/Compliance xcisionmedicalsystems Source Type: news

Women not getting recommended breast radiation therapy
Almost 10% of women don't receive radiation therapy after breast conservation...Read more on AuntMinnie.comRelated Reading: ASTRO: Breast radiation 'less scary' than expected JCO releases new sentinel node biopsy guidelines ASTRO: Radiation boost cuts local recurrence in DCIS patients Choosing Wisely boosts use of short-course breast radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2017 Category: Radiology Source Type: news

Why More Women Are Getting a Double Mastectomy
Recent research has shown that despite more having more treatment options, women with cancer in one breast are increasingly choosing to remove both breasts—even though experts in the field say the procedure is not necessarily accompanied by better outcomes. Now, a new study published Wednesday in JAMA Surgery finds that the increase is being driven in part by their surgeons. Doctors generally discourage contralateral prophylactic mastectomy—also known as CPM, or the removal of a healthy breast when the other has cancer—for women at an average risk for additional breast cancer. They do recommend it for wo...
Source: TIME.com: Top Science and Health Stories - September 13, 2017 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized Breast Cancer breast cancer treatment contralateral prophylactic mastectomy double mastectomy lumpectomy symptoms breast cancer Source Type: news

Dune Medical relocates US HQ to Atlanta
Dune Medical Devices said today it is relocating its US headquarters to Alpharetta, Ga., near Atlanta, from Paoli, Penn. as the company looks to expand its portfolio and improve uptake and reimbursement for its MarginProbe device. The MarginProbe is a breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries, the company said. The system uses the company’s proprietary radiofrequency spectroscopy technology to help surgeons identify microscopic residual cancer at surgical margins during surgery. “Dune’s proprietary technology is already demonstrating high value...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dune Medical Devices Inc. Source Type: news

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
(Wiley) A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2017 Category: International Medicine & Public Health Source Type: news

Effect of Radiotherapy in Breast Cancer Similar Across Subtypes
Breast cancer subtypes generally did not respond differently to radiotherapy following breast-conserving surgery, according to long-term follow-up of a randomized trial. (Source: CancerNetwork)
Source: CancerNetwork - August 5, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Radiation Oncology Source Type: news

Benefit of Radiotherapy After Breast Conservation in DCIS Benefit of Radiotherapy After Breast Conservation in DCIS
Can this molecular assay help determine who will benefit from radiotherapy after breast-conserving therapy for DCIS?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

MRI Plus Mammography Improves Screening After Breast Conservation MRI Plus Mammography Improves Screening After Breast Conservation
Adding MRI or ultrasonography to mammography improves detection of new breast cancers in younger women who have had breast conservation therapy (BCT) for breast cancer, a new study finds.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - June 28, 2017 Category: Radiology Tags: Radiology News Source Type: news

Adding MRI to Mammography Ups Detection of Breast Cancer
Findings in women aged ≤ 50 years who had undergone breast conservation therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 26, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Radiology, Surgery, Journal, Source Type: news

Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
(The JAMA Network Journals) A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2017 Category: Cancer & Oncology Source Type: news

Many TNBC Patients Unnecessarily Opt for Mastectomy
The use of neoadjuvant chemotherapy increases eligibility for breast-conserving therapy in triple-negative breast cancer patients, yet many still opt for mastectomy. (Source: CancerNetwork)
Source: CancerNetwork - June 16, 2017 Category: Cancer & Oncology Authors: Mark Fuerst Tags: Breast Cancer News Triple-Negative Breast Cancer Source Type: news

As bike commuting soars, so do injuries. Annual medical costs are now in the billions.
Bikes have transformed urban landscapes throughout America, from pavement markings on streets to our workday gear, and most of us agree it's a good thing. They've reduced the pollution we send into the ozone layer, helped us conserve gas and oil and kept us fitter than we might otherwise be. But there's also been a downside […]Related:Is pregnancy safe after breast cancer? Here’s what the latest data shows.‘Drug tourists’ keep overdosing at this library. Here’s how employees are saving their lives.Professor who campaigned to ban trans fats dies at 102 (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 3, 2017 Category: Consumer Health News Source Type: news

Combined optical and molecular imaging could guide breast-conserving surgery
(Society of Nuclear Medicine) Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries. Now, in a first-in-human study, British researchers have provided a possible solution using Cerenkov luminescence imaging (CLI), which combines optical and molecular imaging. The study is covered in the featured article of The Journal of Nuclear Medicine's June 2017 issue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2017 Category: Cancer & Oncology Source Type: news

Decision Making in the Surgical Management of Invasive Breast Cancer —Part 1: Lumpectomy, Mastectomy, and Contralateral Prophylactic Mastectomy
Breast-conserving surgery and mastectomy are equivalent treatments for invasive breast cancer patients in terms of overall survival. For the majority of patients, successful breast conservation requires a margin-negative lumpectomy and access to WBRT. CPM yields no definitive survival advantage. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2017 Category: Cancer & Oncology Authors: Lisa A. Newman, MD, MPH Tags: Breast Cancer Oncology Journal Review Article Source Type: news

Decision Making in the Surgical Management of Invasive Breast Cancer —Part 2: Expanded Applications for Breast-Conserving Surgery
This article will detail current management approaches to achieving breast conservation in patients with invasive breast cancer, including cases of bulky tumors and/or multiple tumors. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2017 Category: Cancer & Oncology Authors: Lisa A. Newman, MD, MPH Tags: Breast Cancer Oncology Journal Review Article Source Type: news

7 medtech stories we missed this week: April 7, 2017
[Image from unsplash.com]New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking. Here are some medtech stories we missed this week but thought were still worth mentioning. 1. AMNIOX touts new umbilical cord study AMNIOX Medical announced that it has published the results of 3 studies that demonstrate the effectiveness of umbilical cord tissue for treating chronic wounds, according to an April 7 press release. The company’s cryopreserved human umbilical cord tissue, NEOX Cord 1K was tested on 29 patients who needed a wound all...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Radiosurgery Regulatory/Compliance Research & Development Spinal Wound Care Aesculap Implant Systems Amniox AngioDynamics Cianna Medical InVivo Therapeutics MedTech Nu-Med Occlutech Source Type: news

Breast Conservation Therapy Preferred Local Treatment Option for Stage II Disease
Breast conservation therapy is usually best for local treatment for stage II breast cancer —and biology, as well as stage, drives patient outcomes. (Source: CancerNetwork)
Source: CancerNetwork - March 13, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Breast Cancer Conferences/MBCC 2017 News Source Type: news

Older women less likely to be offered breast reconstruction after mastectomy
Guidelines state that surgeons should discuss breast reconstruction with all suitable patients Related items fromOnMedica Tamoxifen linked to reduced contralateral breast cancer risk Big data advances breast cancer research by ‘decades’ Breast conservation beats mastectomy for some patients Schoolboy youngest in UK to undergo mastectomy Study finds overuse of double mastectomy (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 8, 2017 Category: UK Health Source Type: news

Breast Conserving Surgery Plus RT Better Than Mastectomy in Some Patients
A large registry study found that certain breast cancer patients gain a significant survival benefit with breast conserving surgery plus radiation therapy compared with mastectomy (Source: CancerNetwork)
Source: CancerNetwork - February 7, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news

Better Survival After Breast Conservation Than Mastectomy Better Survival After Breast Conservation Than Mastectomy
Performing breast-conserving therapy may offer survival benefits over mastectomy, particularly in older women who have earlier-stage disease and other conditions, suggests a large observational study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ECC Roundup: Breast Conservation Benefit Varies by Age
(MedPage Today) -- And other reports from the European Cancer Congress (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - January 31, 2017 Category: Endocrinology Source Type: news

More survive breast cancer without full mastectomy
The largest scientific breast cancer study ever conducted looked at the results of 130,000 patients. The results found that women were a third more likely to survive if they had breast-conserving surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2017 Category: Consumer Health News Source Type: news

Some early breast cancer patients benefit more from breast conservation than from mastectomy
Breast conserving therapy (BCT) is better than mastectomy for patients with some types of early breast cancer, according to results from the largest study to date. Researchers report that considerably superior survival, both specific to breast cancer and from any cause of death, was found among certain groups of patients who had had BCT. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 29, 2017 Category: Science Source Type: news

Breast conservation beats mastectomy for some patients
New findings presented at European Cancer Congress Related items fromOnMedica Breast cancer screening One in six breast cancer patients have symptom other than a lump Study finds overuse of double mastectomy Partial radiotherapy suitable for early breast cancer Radiotherapy during breast cancer surgery cuts cost and time (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 29, 2017 Category: UK Health Source Type: news

Some early breast cancer patients benefit more from breast conservation than from mastectomy
(ECCO-the European CanCer Organisation) Breast conserving therapy (BCT) is better than mastectomy for patients with some types of early breast cancer, according to results from the largest study to date, presented at ECC2017. Dutch researchers report that considerably superior survival, both specific to breast cancer and from any cause of death, was found among certain groups of patients who had had BCT. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2017 Category: Global & Universal Source Type: news

Reoperation Rates 3-Fold Higher After DCIS Than IBC Reoperation Rates 3-Fold Higher After DCIS Than IBC
Patients undergoing breast-conserving surgery had reoperation rates 3 times higher when when their diagnosis was ductal carcinoma in situ (DCIS) than when it was invasive breast cancer (IBC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Potentially avoidable breast cancer surgeries cost patients and health-care system
(University of British Columbia Okanagan campus) A recent study by UBC medical researchers examined the health care costs associated with lumpectomy patients requiring reoperations. A lumpectomy, known as breast conservation surgery, is a procedure that removes tumors, aims to conserve breast tissue, and is followed by radiation therapy.The study concluded that with Canadian reoperation rates being more than double recommended targets, the additional cost to BC's health care system alone is $2 million per year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 15, 2016 Category: Cancer & Oncology Source Type: news

Local Recurrence Less Likely With Mastectomy in Younger Breast Cancer Patients
Over the long term, local recurrence is more likely in young women with invasive breast cancer who undergo breast conserving surgery compared with those who undergo mastectomy, though survival is no different. (Source: CancerNetwork)
Source: CancerNetwork - December 12, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Conferences/SABCS 2016 Source Type: news

Advances in treatment may mean women with breast cancer should be spared mastectomies
Professor Mike Dixon, consultant surgeon at the Edinburgh Breast Unit, said breast-conserving surgery, which involves removing the lump and having drug therapy, has ‘better outcomes’. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2016 Category: Consumer Health News Source Type: news

Repeat Breast Conservation Safe, Effective (CME/CE)
(MedPage Today) -- Low recurrence rate, high survival (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 30, 2016 Category: Hematology Source Type: news

How much is enough: two new priority review updates on radiotherapy for breast cancer
 Reposted with permission from Cochrane AustraliaFor many women with breast cancer, the use of post-operative radiotherapy will allow them to undergo less extensive surgery. In mid-July, Brisbane-based Radiation Oncologist Brigid Hickey and colleagues from Australia and New Zealand published two review updates that consider critical questions about the size of the doses in which radiation is given. Here, Brigid shares her thoughts on the important findings of both reviews.‘So who gets breast cancer? Women with families, women with jobs, women with busy lives,’ says Brigid. ‘So from a patient perspect...
Source: Cochrane News and Events - September 26, 2016 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

After long-term follow-up, study looks at prognostic factors for breast cancer
A new study represents a long-term analysis of prognostic factors among some patients with breast cancer who were treated with breast-conserving therapy in the EORTC " boost no boost " trial, which evaluated the influence of a " boost " dose in radiotherapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 8, 2016 Category: Science Source Type: news

After long-term follow-up, study looks at prognostic factors for breast cancer
(The JAMA Network Journals) A new study published online by JAMA Oncology is long-term analysis of prognostic factors among some patients with breast cancer who were treated with breast-conserving therapy in the EORTC 'boost no boost' trial, which evaluated the influence of a 'boost' dose in radiotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 8, 2016 Category: Cancer & Oncology Source Type: news